These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 6685452)
1. Pharmacokinetics of aztreonam in patients with various degrees of renal dysfunction. Mihindu JC; Scheld WM; Bolton ND; Spyker DA; Swabb EA; Bolton WK Antimicrob Agents Chemother; 1983 Aug; 24(2):252-61. PubMed ID: 6685452 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of aztreonam in patients with chronic renal failure. Fillastre JP; Leroy A; Baudoin C; Humbert G; Swabb EA; Vertucci C; Godin M Clin Pharmacokinet; 1985; 10(1):91-100. PubMed ID: 4038635 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of ceftizoxime in subjects with various degrees of renal function. Kowalsky SF; Echols RM; Venezia AR; Andrews EA Antimicrob Agents Chemother; 1983 Aug; 24(2):151-5. PubMed ID: 6314884 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of carumonam (AMA-1080) in patients with impaired renal function and in those undergoing hemodialysis. Konishi K; Suzuki H; Saruta T; Deguchi N; Fugono T Antimicrob Agents Chemother; 1991 Jun; 35(6):1048-52. PubMed ID: 1929242 [TBL] [Abstract][Full Text] [Related]
5. Mezlocillin pharmacokinetics after single intravenous doses to patients with varying degrees of renal function. Frimodt-Möller N; Maigaard S; Toothaker RD; Bundtzen RW; Brodey MV; Craig WA; Welling PG; Madsen PO Antimicrob Agents Chemother; 1980 Apr; 17(4):599-607. PubMed ID: 6446877 [TBL] [Abstract][Full Text] [Related]
6. Single-dose pharmacokinetics of aztreonam in pediatric patients. Stutman HR; Marks MI; Swabb EA Antimicrob Agents Chemother; 1984 Aug; 26(2):196-9. PubMed ID: 6541452 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of carumonam in patients with renal insufficiency. Horber F; Egger HJ; Weidekamm E; Dubach UC; Frey FJ; Probst PJ; Stoeckel K Antimicrob Agents Chemother; 1986 Jan; 29(1):116-21. PubMed ID: 3729324 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of cefoperazone (2.0 g) and sulbactam (1.0 g) coadministered to subjects with normal renal function, patients with decreased renal function, and patients with end-stage renal disease on hemodialysis. Reitberg DP; Marble DA; Schultz RW; Whall TJ; Schentag JJ Antimicrob Agents Chemother; 1988 Apr; 32(4):503-9. PubMed ID: 3377461 [TBL] [Abstract][Full Text] [Related]
10. Single-dose pharmacokinetics of aztreonam in healthy volunteers and renal failure patients. el Guinaidy MA; Nawishy S; Abd el Bary M; Sabbour MS J Chemother; 1989 Jun; 1(3):164-9. PubMed ID: 2795125 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of intravenously administered ciprofloxacin in patients with various degrees of renal function. Drusano GL; Weir M; Forrest A; Plaisance K; Emm T; Standiford HC Antimicrob Agents Chemother; 1987 Jun; 31(6):860-4. PubMed ID: 3619418 [TBL] [Abstract][Full Text] [Related]
12. Metabolism and pharmacokinetics of aztreonam in healthy subjects. Swabb EA; Singhvi SM; Leitz MA; Frantz M; Sugerman A Antimicrob Agents Chemother; 1983 Sep; 24(3):394-400. PubMed ID: 6685455 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of cefaclor and cephalexin: dosage nomograms for impaired renal function. Spyker DA; Thomas BL; Sande MA; Bolton WK Antimicrob Agents Chemother; 1978 Aug; 14(2):172-7. PubMed ID: 697345 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of moxalactam in subjects with normal and impaired renal function. Leroy A; Humbert G; Fillastre JP Antimicrob Agents Chemother; 1981 Jun; 19(6):965-71. PubMed ID: 6455967 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of Aztreonam Dosing Regimens in Patients With Normal and Impaired Renal Function: A Population Pharmacokinetic Modeling and Monte Carlo Simulation Analysis. Xu H; Zhou W; Zhou D; Li J; Al-Huniti N J Clin Pharmacol; 2017 Mar; 57(3):336-344. PubMed ID: 27530649 [TBL] [Abstract][Full Text] [Related]
18. Single-dose pharmacokinetics of lomefloxacin in patients with normal and impaired renal function. Nilsen OG; Saltvedt E; Walstad RA; Marstein S Am J Med; 1992 Apr; 92(4A):38S-40S. PubMed ID: 1316068 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of moxalactam in subjects with various degrees of renal dysfunction. Bolton WK; Scheld WM; Spyker DA; Overby TL; Sande MA Antimicrob Agents Chemother; 1980 Dec; 18(6):933-8. PubMed ID: 6453555 [TBL] [Abstract][Full Text] [Related]
20. Teicoplanin pharmacokinetics in patients with chronic renal failure. Bonati M; Traina GL; Villa G; Salvadeo A; Gentile MG; Fellin G; Rosina R; Cavenaghi L; Buniva G Clin Pharmacokinet; 1987 Apr; 12(4):292-301. PubMed ID: 2954735 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]